1,2-di(propan-2-yl)benzimidazole;2,5-di(propan-2-yl)-1H-imidazole;tetrakis(2-methylpropane);2-methyl-N-propan-2-ylpropanamide;2-propan-2-yl-1H-benzimidazole;2-propan-2-yl-1,3-benzothiazole;2-propan-2-yl-1,3-benzoxazole
C75H123N9O2S — CID 158131261
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1,2-di(propan-2-yl)benzimidazole;2,5-di(propan-2-yl)-1H-imidazole;tetrakis(2-methylpropane);2-methyl-N-propan-2-ylpropanamide;2-propan-2-yl-1H-benzimidazole;2-propan-2-yl-1,3-benzothiazole;2-propan-2-yl-1,3-benzoxazole
1,2-di(propan-2-yl)benzimidazole;2,5-di(propan-2-yl)-1H-imidazole;tetrakis(2-methylpropane);2-methyl-N-propan-2-ylpropanamide;2-propan-2-yl-1H-benzimidazole;2-propan-2-yl-1,3-benzothiazole;2-propan-2-yl-1,3-benzoxazole (PubChem CID 158131261) has the molecular formula C75H123N9O2S and a molecular weight of 1214.94 g/mol. Its IUPAC name is 1,2-di(propan-2-yl)benzimidazole;2,5-di(propan-2-yl)-1H-imidazole;tetrakis(2-methylpropane);2-methyl-N-propan-2-ylpropanamide;2-propan-2-yl-1H-benzimidazole;2-propan-2-yl-1,3-benzothiazole;2-propan-2-yl-1,3-benzoxazole.
Molecular Properties
| Compound Name | 1,2-di(propan-2-yl)benzimidazole;2,5-di(propan-2-yl)-1H-imidazole;tetrakis(2-methylpropane);2-methyl-N-propan-2-ylpropanamide;2-propan-2-yl-1H-benzimidazole;2-propan-2-yl-1,3-benzothiazole;2-propan-2-yl-1,3-benzoxazole |
|---|---|
| PubChem CID | 158131261 |
| Molecular Formula | C75H123N9O2S |
| Molecular Weight | 1214.94 g/mol |
| Exact Mass | 1213.95 |
| IUPAC Name | 1,2-di(propan-2-yl)benzimidazole;2,5-di(propan-2-yl)-1H-imidazole;tetrakis(2-methylpropane);2-methyl-N-propan-2-ylpropanamide;2-propan-2-yl-1H-benzimidazole;2-propan-2-yl-1,3-benzothiazole;2-propan-2-yl-1,3-benzoxazole |
| SMILES | CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)NC(=O)C(C)C.CC(C)c1cnc(C(C)C)[nH]1.CC(C)c1nc2ccccc2[nH]1.CC(C)c1nc2ccccc2n1C(C)C.CC(C)c1nc2ccccc2o1.CC(C)c1nc2ccccc2s1 |
| InChI | InChI=1S/C13H18N2.C10H12N2.C10H11NO.C10H11NS.C9H16N2.C7H15NO.4C4H10/c1-9(2)13-14-11-7-5-6-8-12(11)15(13)10(3)4;3*1-7(2)10-11-8-5-3-4-6-9(8)12-10;1-6(2)8-5-10-9(11-8)7(3)4;1-5(2)7(9)8-6(3)4;4*1-4(2)3/h5-10H,1-4H3;3-7H,1-2H3,(H,11,12);2*3-7H,1-2H3;5-7H,1-4H3,(H,10,11);5-6H,1-4H3,(H,8,9);4*4H,1-3H3 |
| InChIKey | FSULPRWBUYTOLC-UHFFFAOYSA-N |
| XLogP | 23.27 |
| TPSA | 143.20 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 87 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1214.94 |
| LogP ≤ 5 | 23.27 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158131261 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.